For research use only. Not for therapeutic Use.
Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP)[1].
| Catalog Number | I041535 |
| CAS Number | 1792982-57-0 |
| Purity | ≥95% |
| Reference | [1]. Carly Fleagle Chisholm, et al. Thermostable Ebola virus vaccine formulations lyophilized in the presence of aluminum hydroxide. Eur J Pharm Biopharm. 2019 Mar;136:213-220. |
